Applicability of Cellular Application in Diabetes Type 2 Patients.

• Sponsor: Hadassah Medical Organization (Other)
• Overall Status: Completed
• CT.gov ID: NCT02691273
• Collaborator: (none)
• Enrollment: 9
• Location: 1
• Arm: 1
• Duration (Months): 28
• Patients Per Site Per Month: 0.3

Study Details

Study Description

Brief Summary

It was found that an important part of the factors impeding adherence to medication and a healthy lifestyle among the chronically ill diabetic patients lies in proper management of the disease. Since it is a chronic progressive disease the caregiver is the patient himself.Studies have shown that software system, sending text messages / messages / reminders daily and answering questionnaires can improve adherence to a change in lifestyle.

This study is an initial pilot study , which examines Feasibility ( Applicability ) of using a smart application that promotes a healthy lifestyle perseverance parallel use relaxation techniques .

Condition or Disease	Intervention/Treatment	Phase
Diabetes Mellitus, Type 2	Behavioral: cellular application treating diabetes using breathing technique	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 9 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Study Start Date: Mar 1, 2015
• Actual Primary Completion Date: Mar 1, 2017
• Actual Study Completion Date: Jul 1, 2017

Arms and Interventions

Arm	Intervention/Treatment
Experimental: breathing technique this arm includes learning breathing technique using the patient's smartphone.	Behavioral: cellular application treating diabetes using breathing technique

Outcome Measures

Primary Outcome Measures

1. 10 percentage improvement in the quality of life questionnaire [two months]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 75 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• HbA1c above 7.5.

• Smartphone users.

• English and Hebrew literate.

Exclusion Criteria:

*Pregnancy

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hadassah Medical Organization	Jerusalem		Israel	9112-

Sponsors and Collaborators

• Hadassah Medical Organization

Investigators

• Principal Investigator: Avivit Cohen, Hadassah Medical Organization

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Hadassah Medical Organization
• ClinicalTrials.gov Identifier: NCT02691273
• Other Study ID Numbers: NM01-HMO-CTIL
• First Posted: Feb 25, 2016
• Last Update Posted: Nov 28, 2017
• Last Verified: Aug 1, 2017

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Additional relevant MeSH terms: Diabetes Mellitus, Type 2

Study Results

No Results Posted as of Nov 28, 2017